drug discovery

Phenotypic vs. target-based screening: why drug discovery is still splitting, and why that matters Drug discovery never really settled the argument between target-based screening and phenotypic screening. Instead, the field has spent the last two decades swinging between them, learning that each...

In a groundbreaking collaboration, Basecamp Research has partnered with tech giants Microsoft and NVIDIA to revolutionize biological research through advanced artificial intelligence (AI) and machine learning technologies. This alliance aims to digitize nature by transforming biological...

AI is fundamentally transforming the way scientific discovery unfolds, shaping research paths and unlocking answers to questions once considered out of reach. Today, as generative AI models mature and their influence stretches from laboratory benches to forests and deep oceans, their potential...

The accelerating integration of artificial intelligence (AI) in biomedical research is ushering in a profound transformation—one that not only speeds up the discovery of new treatments but also redefines the scientific process, the structure of clinical trials, and the very nature of how we view...

The tempo of business transformation is accelerating—and nowhere is this more evident than in the surge of artificial intelligence adoption across leading organizations in 2025. The data is compelling: IDC’s 2025 CEO Priorities research reports that a majority of global CEOs see innovation...

Density Functional Theory (DFT) has long been a foundational computational method, underpinning a vast array of breakthroughs in chemistry, physics, and materials science. At its core, DFT provides a practical means to predict how matter organizes and interacts at the quantum level, delivering...

The realm of computational chemistry stands on the threshold of a transformative revolution, thanks to a groundbreaking integration of deep learning with density functional theory (DFT). Long considered the workhorse of atomistic simulation, DFT is central to the predictive modeling of molecular...

Deep Intelligent Pharma (DIP) has unveiled a groundbreaking generative AI platform at Microsoft Build 2025, signaling a transformative shift in pharmaceutical research and development. This innovative solution, developed in collaboration with Microsoft Azure O3, leverages multi-agent AI swarms...

Microsoft’s much-anticipated unveiling of its Discovery platform at Build 2025 signals a pivotal moment in the ongoing reinvention of research and development for science and engineering. Over the past decade, R&D has been touched by artificial intelligence, high-performance computing, and...

AI is rapidly rewriting the future of healthcare and life sciences, no longer confined to the realm of visionaries or speculative startups, but actively reshaping the way institutions accelerate scientific breakthroughs, boost clinician productivity, and enhance the overall patient experience...

Microsoft Research is once again setting a new benchmark in artificial intelligence innovation with its breakthrough project, Chimera. Unveiled during a recent Microsoft Research Forum session, Chimera promises to dramatically accelerate the drug discovery process by accurately predicting...

The boundaries of scientific discovery are being redrawn by artificial intelligence—and nowhere is this more evident than in Microsoft Research's latest breakthrough. In a recent blog post titled "Exploring the Structural Changes Driving Protein Function with BioEmu-1", researchers detailed how...